Abstract
Introduction
Tranexamic acid (TXA) is being increasingly utilized to reduce blood loss after knee joint arthroplasty. However, there is a lack of studies on the effect of topical TXA on the functional outcomes and quality of life after Unicompartmental Knee Arthroplasty (UKA). The aim of this study was to determine the effect of topical TXA on functional outcomes and quality of life scores in patients undergoing UKA.
Materials and methods
We retrospectively analysed patients undergoing unilateral UKA at a single tertiary hospital from 2005 to 2017. Patients were divided into 2 groups: (1) The control group which did not receive TXA (n = 742); (2) The TXA group which received topical TXA (n = 331). Functional outcomes were assessed using the Knee Society Function Score (KSFS), Knee Society Knee Score (KSKS) and Oxford Knee Score (OKS), while quality of life was evaluated with the Physical Component Score (PCS) and Mental Component Score (MCS) of Short-Form 36 (SF-36) preoperatively and at 6 months and 2 years follow-up.
Results
At 6 months and 2 years post-surgery, there were no significant differences in the functional scores between the groups. The number of patients who attained minimum clinically important difference (MCID) for each of the functional scores was also comparable between the groups.
Conclusions
In patients undergoing UKA, functional outcomes and quality of life scores were comparable between those who received topical TXA and those who did not. There was no significant improvement or impairment in knee function associated with topical TXA administration in UKA up to 2 years follow-up.
Similar content being viewed by others
References
Wong J, Abrishami A, El Beheiry H, Mahomed NN, Roderick Davey J, Gandhi R, Syed KA, Muhammad Ovais Hasan S, De Silva Y, Chung F (2010) Topical application of tranexamic acid reduces postoperative blood loss in total knee arthroplasty: a randomized, controlled trial. J Bone Joint Surg Am 92(15):2503–2513. https://doi.org/10.2106/JBJS.I.01518
Fillingham YA, Ramkumar DB, Jevsevar DS, Yates AJ, Shores P, Mullen K, Bini SA, Clarke HD, Schemitsch E, Johnson RL, Memtsoudis SG, Sayeed SA, Sah AP, Della Valle CJ (2018) The efficacy of tranexamic acid in total knee arthroplasty: a network meta-analysis. J Arthroplasty 33(10):3090–3098. https://doi.org/10.1016/j.arth.2018.04.043
Chen JY, Rikhraj IS, Zhou Z, Tay DK, Chin PL, Chia SL, Lo NN, Yeo SJ (2014) Can tranexamic acid and hydrogen peroxide reduce blood loss in cemented total knee arthroplasty? Arch Orthop Trauma Surg 134(7):997–1002. https://doi.org/10.1007/s00402-014-1958-z
Georgiadis AG, Muh SJ, Silverton CD, Weir RM, Laker MW (2013) A prospective double-blind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 28(8):78–82. https://doi.org/10.1016/j.arth.2013.03.038
Gomez-Barrena E, Ortega-Andreu M, Padilla-Eguiluz NG, Perez-Chrzanowska H, Figueredo-Zalve R (2014) Topical intra-articular compared with intravenous tranexamic acid to reduce blood loss in primary total knee replacement: a double-blind, randomized, controlled, noninferiority clinical trial. J Bone Joint Surg Am 96(23):1937–1944. https://doi.org/10.2106/JBJS.N.00060
Wu J, Feng S, Chen X, Lv Z, Qu Z, Chen H, Xue C, Zhu M, Guo K, Wu P (2019) Intra-articular injection of tranexamic acid on perioperative blood loss during unicompartmental knee arthroplasty. Med Sci Monit 25:5068–5074. https://doi.org/10.12659/MSM.914817
Suarez JC, Saxena A, Arguelles W, Watson Perez JM, Ramamoorthy V, Hernandez Y, Osondu CU (2022) Unicompartmental knee arthroplasty vs total knee arthroplasty: a risk-adjusted comparison of 30-day outcomes using national data from 2014 to 2018. Arthroplast Today 17:114–119. https://doi.org/10.1016/j.artd.2022.06.017
Schwab PE, Lavand’homme P, Yombi JC, Thienpont E (2015) Lower blood loss after unicompartmental than total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 23(12):3494–3500. https://doi.org/10.1007/s00167-014-3188-x
Yeh JZ, Chen JY, Bin Abd Razak HR, Loh BH, Hao Y, Yew AK, Chia SL, Lo NN, Yeo SJ (2016) Preoperative haemoglobin cut-off values for the prediction of post-operative transfusion in total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 24(10):3293–3298. https://doi.org/10.1007/s00167-016-4183-1
Zhu Z, Tong P (2021) Association between type of anesthesia and risk of blood transfusion events in primary unilateral total knee arthroplasty: a secondary analysis based on a cohort study in Singapore. J Knee Surg 34(10):1120–1125. https://doi.org/10.1055/s-0040-1701486
Grosso MJ, Trofa DP, Danoff JR, Hickernell TR, Murtaugh T, Lakra A, Geller JA (2018) Tranexamic acid increases early perioperative functional outcomes after total knee arthroplasty. Arthroplast Today 4(1):74–77. https://doi.org/10.1016/j.artd.2017.05.009
Jacob B, Kloss N, Bohle S, Kirschberg J, Zippelius T, Heinecke M, Matziolis G, Rohner E (2020) Tranexamic acid is toxic on human chondrocytes, in vitro. J Orthop 20:1–5. https://doi.org/10.1016/j.jor.2019.12.008
Kagoma YK, Crowther MA, Douketis J, Bhandari M, Eikelboom J, Lim W (2009) Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 123(5):687–696. https://doi.org/10.1016/j.thromres.2008.09.015
Patel JN, Spanyer JM, Smith LS, Huang J, Yakkanti MR, Malkani AL (2014) Comparison of intravenous versus topical tranexamic acid in total knee arthroplasty: a prospective randomized study. J Arthroplasty 29(8):1528–1531. https://doi.org/10.1016/j.arth.2014.03.011
Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM (2011) Tranexamic acid in total knee replacement: a systematic review and meta-analysis. J Bone Joint Surg Br 93(12):1577–1585. https://doi.org/10.1302/0301-620X.93B12.26989
Insall JN, Dorr LD, Scott RD, Scott WN (1989) Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res 248:13–14
Dawson J, Fitzpatrick R, Murray D, Carr A (1998) Questionnaire on the perceptions of patients about total knee replacement. J Bone Joint Surg Br 80(1):63–69. https://doi.org/10.1302/0301-620x.80b1.7859
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Lee WC, Kwan YH, Chong HC, Yeo SJ (2017) The minimal clinically important difference for Knee Society Clinical Rating System after total knee arthroplasty for primary osteoarthritis. Knee Surg Sports Traumatol Arthrosc 25(11):3354–3359. https://doi.org/10.1007/s00167-016-4208-9
Clement ND, MacDonald D, Simpson AH (2014) The minimal clinically important difference in the Oxford knee score and Short Form 12 score after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc 22(8):1933–1939. https://doi.org/10.1007/s00167-013-2776-5
Serrano Mateo L, Goudarz Mehdikhani K, Caceres L, Lee YY, Gonzalez Della Valle A (2016) Topical tranexamic acid may improve early functional outcomes of primary total knee arthroplasty. J Arthroplasty 31(7):1449–1452. https://doi.org/10.1016/j.arth.2016.01.009
Alshryda S, Mason J, Vaghela M, Sarda P, Nargol A, Maheswaran S, Tulloch C, Anand S, Logishetty R, Stothart B, Hungin AP (2013) Topical (intra-articular) tranexamic acid reduces blood loss and transfusion rates following total knee replacement: a randomized controlled trial (TRANX-K). J Bone Joint Surg Am 95(21):1961–1968. https://doi.org/10.2106/JBJS.L.00907
Jeer PJ, Cossey AJ, Keene GC (2005) Haemoglobin levels following unicompartmental knee arthroplasty: influence of transfusion practice and surgical approach. Knee 12(5):358–361. https://doi.org/10.1016/j.knee.2004.11.006
Moo IH, Chen JYQ, Pagkaliwaga EH, Tan SW, Poon KB (2017) Bone wax is effective in reducing blood loss after total knee arthroplasty. J Arthroplasty 32(5):1483–1487. https://doi.org/10.1016/j.arth.2016.12.028
Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ (2014) Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 472(1):66–72. https://doi.org/10.1007/s11999-013-3134-0
Waddell BS, Zahoor T, Meyer M, Ochsner L, Chimento G (2016) Topical tranexamic acid use in knee periprosthetic joint infection is safe and effective. J Knee Surg 29(5):423–429. https://doi.org/10.1055/s-0035-1564599
Wu C, Tan C, Wang L (2020) Higher doses of topical tranexamic acid safely improves immediate functional outcomes and reduces transfusion requirement in total knee arthroplasty. Arch Orthop Trauma Surg 140(12):2071–2075. https://doi.org/10.1007/s00402-020-03591-4
Parker JD, Lim KS, Kieser DC, Woodfield TBF, Hooper GJ (2018) Is tranexamic acid toxic to articular cartilage when administered topically? What is the safe dose? Bone Joint J 100-B(3):404–412. https://doi.org/10.1302/0301-620X.100B3.BJJ-2017-1135.R1
Levent A, Kose O, Linke P, Gehrke T, Citak M (2021) Tranexamic acid is safe and effective in patients with heterozygous factor V Leiden mutation during total joint arthroplasty. Arch Orthop Trauma Surg. https://doi.org/10.1007/s00402-021-04110-9
King MT (2011) A point of minimal important difference (MID): a critique of terminology and methods. Expert Rev Pharmacoecon Outcomes Res 11(2):171–184. https://doi.org/10.1586/erp.11.9
Polascik BW, Bin Abd Razak HR, Chong HC, Lo NN, Yeo SJ (2018) Acceptable functional outcomes and patient satisfaction following total knee arthroplasty in Asians with severe knee stiffness: a matched analysis. Clin Orthop Surg 10(3):337–343. https://doi.org/10.4055/cios.2018.10.3.337
Moorthy V, Chen JY, Liow MHL, Chin PL, Chia SL, Lo NN, Yeo SJ (2021) Mid-term functional outcomes of patient-specific versus conventional instrumentation total knee arthroplasty: a prospective study. Arch Orthop Trauma Surg 141(4):669–674. https://doi.org/10.1007/s00402-020-03729-4
Moorthy V, Lai MC, Liow MHL, Chen JY, Pang HN, Chia SL, Lo NN, Yeo SJ (2021) Similar postoperative outcomes after total knee arthroplasty with measured resection and gap balancing techniques using a contemporary knee system: a randomized controlled trial. Knee Surg Sports Traumatol Arthrosc 29(10):3178–3185. https://doi.org/10.1007/s00167-020-06103-4
Funding
This work was supported by the FY2017 SingHealth DUKE-NUS Musculoskeletal Sciences Academic Clinical Programme Research Support Programme Grant [Project No.: 13/FY2017/P1/16-A30].
Author information
Authors and Affiliations
Contributions
All authors contributed in conceptualization; data curation; formal analysis; funding acquisition; investigation; methodology; project administration; resources; supervision; writing.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Centralised Institutional Review Board (CIRB) (No. 2011/517/D). Institutional review board’s approval (IRB reference: 2020/2309).
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Moorthy, V., Chen, J.Y., Liow, M.H.L. et al. The effect of topical tranexamic acid on functional outcomes and quality of life in patients undergoing unicompartmental knee arthroplasty. Arch Orthop Trauma Surg 143, 4395–4400 (2023). https://doi.org/10.1007/s00402-022-04711-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-022-04711-y